Skip to main content

Animations

MJFF Publications

4721 - 4730 of 6570 Results
Title
Year
  • Year
  • 2026
  • 2026
  • 2013
  • 2026
  • 2026
  • 2026
  • 2026
  • 2026
  • 2026
  • 2026
  • Summary Details
    OPEN
    Title: Functional Blood‐Brain Barrier Crossing by Biomimetic M13 Phage Vectors for Targeted Neuronal Delivery
    Journal Name: Advanced Healthcare Materials
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/adhm.202600029
    Citation Count: 0
  • Summary Details
    OPEN
    Title: LRRK2 G2019S variant is associated with transcriptional changes in Parkinson’s disease human myeloid cells under proinflammatory environment
    Journal Name: Journal of Neuroinflammation
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12974-026-03967-0
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Money without collaboration won't bring cures
    Journal Name: Nature Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/nm0213-127
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Protocol for SEC-based isolation and characterization of human plasma-derived extracellular vesicles
    Journal Name: STAR Protocols
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.xpro.2026.104735
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Protocol for classifying cellular senescence from single-cell and single-nucleus RNA sequencing data
    Journal Name: STAR Protocols
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.xpro.2026.104724
    Citation Count: 0
  • Summary Details
    OPEN
    Title: An automated workflow for quantifying the formation of synuclein aggregates in human dopaminergic neurons
    Journal Name: Methods
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.ymeth.2026.06.005
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Preclinical evaluation of nitrated α-synuclein-specific CAR-Treg therapy in Parkinson’s disease
    Journal Name: Cell Reports Medicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.xcrm.2026.102983
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Hypertension acts together with Aβ pathology in late-life to promote memory loss
    Journal Name: The Journal of Prevention of Alzheimer's Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.tjpad.2026.100579
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Shortened olfactory identification testing to differentiate parkinsonian syndromes
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2026.108372
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Continuous subcutaneous foslevodopa/foscarbidopa in advanced Parkinson's disease: A clinical workflow from 50 consecutive patients at a single U.S. center
    Journal Name: Clinical Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1016/j.prdoa.2026.100492
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.